
Cara Therapeutics CARA
Quartalsbericht 2025-Q3
hinzugefügt 13.11.2025
Cara Therapeutics EV 2011-2026 | CARA
EV Jährlich Cara Therapeutics
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 71.1 M | 493 M | 604 M | 685 M | 711 M | 586 M | 471 M | 388 M | 212 M | 178 M | -5.78 M | 1.98 M | 4.58 M |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 711 M | -5.78 M | 338 M |
EV anderer Aktien in der Pharmaeinzelhändler
| Name | EV | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
MorphoSys AG
MOR
|
1.82 B | - | 2.43 % | $ 254 M | ||
|
ARCA biopharma
ABIO
|
436 M | - | 1052.0 % | $ 415 M | ||
|
Acasti Pharma
ACST
|
24 M | - | 4.01 % | $ 150 M | ||
|
Adverum Biotechnologies
ADVM
|
125 M | - | - | $ 86.2 M | ||
|
AgeX Therapeutics
AGE
|
6.28 M | - | -10.17 % | $ 12.2 K | ||
|
Aeglea BioTherapeutics
AGLE
|
-23.2 M | - | - | $ 1.01 B | ||
|
AIkido Pharma
AIKI
|
22.8 M | - | 1.93 % | $ 17.4 M | ||
|
I-Mab
IMAB
|
8.28 B | - | - | $ 866 M | ||
|
Aptorum Group Limited
APM
|
9.45 M | $ 0.81 | 0.15 % | $ 4.42 M | ||
|
argenx SE
ARGX
|
-796 M | $ 836.39 | -0.46 % | $ 25 B | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
1.95 B | - | - | $ 40.3 B | ||
|
Akero Therapeutics
AKRO
|
2.99 B | - | - | $ 3.67 B | ||
|
Ascendis Pharma A/S
ASND
|
849 M | $ 234.52 | -0.2 % | $ 5 B | ||
|
Biophytis SA
BPTS
|
525 M | - | -13.47 % | $ 169 M | ||
|
Albireo Pharma
ALBO
|
417 M | - | -0.23 % | $ 916 M | ||
|
Alterity Therapeutics Limited
ATHE
|
-28.9 M | $ 3.44 | 3.42 % | $ 8.28 B | ||
|
Allena Pharmaceuticals
ALNA
|
-14.1 M | - | 3.16 % | $ 1.9 M | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
3.41 B | - | -1.52 % | $ 24.7 M | ||
|
AlloVir
ALVR
|
-64.1 M | - | 4.14 % | $ 49.1 M | ||
|
Midatech Pharma plc
MTP
|
4.79 M | - | -18.52 % | $ 27.3 M | ||
|
Akouos
AKUS
|
95.1 M | - | 0.23 % | $ 488 M | ||
|
BioVie
BIVI
|
-12.6 M | $ 1.24 | -0.8 % | $ 1.83 M | ||
|
Ampio Pharmaceuticals
AMPE
|
-1.05 M | - | -11.43 % | $ 502 K | ||
|
Applied Molecular Transport
AMTI
|
7.6 M | - | - | $ 10.1 M | ||
|
BioMarin Pharmaceutical
BMRN
|
13.5 B | $ 61.58 | -1.66 % | $ 11.7 B | ||
|
Acorda Therapeutics
ACOR
|
-13.2 M | - | -24.86 % | $ 820 K | ||
|
Atea Pharmaceuticals
AVIR
|
216 M | $ 4.56 | -1.94 % | $ 384 M | ||
|
Acer Therapeutics
ACER
|
38.2 M | - | 2.71 % | $ 14 M | ||
|
Aravive
ARAV
|
58.2 M | - | -13.39 % | $ 1.45 M | ||
|
Институт стволовых клеток человека
ISKJ
|
14.1 M | - | - | - | ||
|
Applied Genetic Technologies Corporation
AGTC
|
-9.16 M | - | - | $ 26.5 M | ||
|
Avenue Therapeutics
ATXI
|
-1.23 M | - | -52.27 % | $ 4.45 M | ||
|
Capricor Therapeutics
CAPR
|
177 M | $ 28.24 | 1.18 % | $ 756 M | ||
|
Axsome Therapeutics
AXSM
|
8.95 B | $ 165.14 | -2.83 % | $ 8.22 B | ||
|
Ayala Pharmaceuticals
AYLA
|
5.32 M | - | - | $ 7.46 M | ||
|
CASI Pharmaceuticals
CASI
|
1.08 B | $ 0.31 | -61.59 % | $ 42.2 M | ||
|
Atreca
BCEL
|
94.8 M | - | -11.76 % | $ 5.79 M | ||
|
Alpine Immune Sciences
ALPN
|
363 M | - | - | $ 2.17 B | ||
|
BioDelivery Sciences International
BDSI
|
445 M | - | -4.8 % | $ 255 M | ||
|
Catalyst Biosciences
CBIO
|
38.1 M | $ 12.21 | -3.48 % | $ 804 M | ||
|
Aeterna Zentaris
AEZS
|
5.52 M | - | 5.93 % | $ 314 M | ||
|
BeiGene, Ltd.
BGNE
|
253 B | - | 0.49 % | $ 251 B | ||
|
Biogen
BIIB
|
37.6 B | $ 191.78 | -1.72 % | $ 28.1 B | ||
|
Bellicum Pharmaceuticals
BLCM
|
-9.74 M | - | -9.72 % | $ 5.89 M | ||
|
Baudax Bio
BXRX
|
29.8 M | - | 0.59 % | $ 63 K | ||
|
Aptose Biosciences
APTO
|
10.8 M | - | -45.71 % | $ 1.2 M | ||
|
Aptinyx
APTX
|
-18.3 M | - | -39.0 % | $ 4.57 M | ||
|
Aridis Pharmaceuticals
ARDS
|
38.2 M | - | 17.91 % | $ 11.1 M | ||
|
BioNTech SE
BNTX
|
-6.64 B | $ 110.5 | -0.35 % | $ 27.2 B | ||
|
Amneal Pharmaceuticals
AMRX
|
1.72 B | $ 14.64 | -0.17 % | $ 4.52 B |